Background illustration for clinical trials search

Paid Clinical Trials Minneapolis

Discover 1,005 paid clinical trials in Minneapolis, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

for
Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC)
Location: Minneapolis MN, Zion IL, Detroit MI, Louisville KY,
Sponsor: J-Pharma Co., Ltd.

Sex: All

Age: 18+

Code: NCT07265674

Phase 3, Recruiting

Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

for
Neuroblastoma
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 0 - 30

Code: NCT02605421

Phase 2, Recruiting

Auto Stem Cell Transplant for Lymphoma Patients

for
Non-Hodgkin Lymphoma, Hodgkin Lymphoma
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 0 - 70+

Code: NCT03125642

Phase 2, Recruiting

Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Minneapolis MN, Columbus OH, Richmond VA
Sponsor: Yazeed Sawalha

Sex: All

Age: 18+

Code: NCT06536049

Phase 1, Phase 2, Recruiting

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

for
Basal Ganglia Germinoma, Diabetes Insipidus, Germinoma,
Location: Minneapolis MN, Rochester MN, Sioux Falls SD, Fargo ND,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT06368817

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

for
Colorectal Carcinoma, Endometrial Carcinoma, Melanoma,
Location: Minneapolis MN, Chicago IL, St Louis MO,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT04851119

Phase 1, Phase 2, Recruiting

Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer

for
Ovarian Cancer, Fallopian Tube, Primary Peritoneal Cancer
Location: Minneapolis MN, Rochester MN, Columbus OH,
Sponsor: University of Alabama at Birmingham

Sex: Female

Age: 18+

Code: NCT04606914

Phase 2, Recruiting

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

for
Metastatic Colorectal Carcinoma,
Location: Minneapolis MN, Rochester MN, Madison WI, Chicago IL,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT05863195

Phase 3, Recruiting

Backtracking Leukemia-Typical Somatic Mutations in Cord Blood

for
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Location: Minneapolis MN
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 25

Code: NCT05014165

Recruiting

PRE-ISPY Phase I/II Oncology Platform Program

for
HER2-positive Breast Cancer, Metastatic Cancer,
Location: Minneapolis MN, New Lenox IL, Orland Park IL,
Sponsor: QuantumLeap Healthcare Collaborative

Sex: All

Age: 18+

Code: NCT05868226

Phase 1, Phase 2, Recruiting

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

for
Duodenal Neoplasm, Pancreatic Neoplasm
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 18+

Code: NCT06411795

Phase 2, Recruiting

Observational Study of Exposure to Environmental Toxicants Among Firefighters

for
Healthy
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 18+

Code: NCT05643014

Recruiting

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

for
Acute Leukemia, Acute Myeloid Leukemia,
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 0 - 60

Code: NCT03314974

Phase 2, Recruiting

MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma

for
Autologous Stem Cell Transplant, Classic Hodgkin Lymphoma
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 18+

Code: NCT06377540

Phase 2, Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Minneapolis MN, Rochester MN, Sioux Falls SD,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase 3, Recruiting

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

for
Acute Myeloid Leukemia Post Cytotoxic Therapy,
Location: Minneapolis MN, Chicago IL, Indianapolis IN,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 21

Code: NCT07012044

Phase 1, Recruiting

Allo HSCT for High Risk Hemoglobinopathies

for
Graft Failure, Sickle Cell Disease, Hemoglobinopathies
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 0 - 55

Code: NCT06872333

Phase 2, Recruiting

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Minneapolis MN, Milwaukee WI, Chicago IL,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 21

Code: NCT04870944

Phase 1, Phase 2, Recruiting

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

for
Prostate Cancer (Adenocarcinoma),
Location: Minneapolis MN, Madison WI, Philadelphia PA,
Sponsor: Prostate Cancer Clinical Trials Consortium

Sex: Male

Age: 18+

Code: NCT06844383

Phase 2, Recruiting

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

for
Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer,
Location: Minneapolis MN, Philadelphia PA, Houston TX,
Sponsor: Fate Therapeutics

Sex: All

Age: 18+

Code: NCT07216105

Phase 1, Recruiting